Literature DB >> 1484086

Determination of cetirizine in serum using reversed-phase high-performance liquid chromatography with ultraviolet spectrophotometric detection.

J Moncrieff1.   

Abstract

A method using reversed-phase high-performance liquid chromatography with ultraviolet detection for the determination of ceterizine in serum is described. The method is sensitive down to 50 ng/ml (250-microliter loop). Sample preparation involves only serum deproteination with perchloric acid and injection of the centrifuged supernatant. Elution is at pH 2.5 with acetonitrile-methanol-0.05 M phosphate buffer (33:9:58, v/v) on a 25 cm x 4.6 mm I.D. Spherisorb S5 ODS2 column. Detection is at 211 nm, its lambda max. For levels above 300 ng/ml the serum sample size is 100 microliter and a 200-microliter sample is necessary for concentrations less than 300 ng/ml. At the 2 micrograms/ml concentration the intra-assay relative standard deviation is better than 2.2%, whilst the inter-assay deviation is 2.6% over eight samples. At 200 ng/ml the intra-assay relative standard deviation is 6% over seven samples. Detector response is linear from 100 ng/ml to 10 micrograms/ml (100-microliter loop).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484086     DOI: 10.1016/0378-4347(92)80354-s

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Pharmacokinetics of cetirizine in tear fluid after a single oral dose.

Authors:  Lucia Grumetto; Gilda Cennamo; Antonio Del Prete; Maria I La Rotonda; Francesco Barbato
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Effect of longterm cetirizine treatment on the cutaneous hypersensitivity reaction in patients with grass pollen allergy.

Authors:  J R Snyman; D K Sommers; M van Wyk; D J Lizamore
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Simultaneous determination of cetirizine, phenyl propanolamine and nimesulide using third derivative spectrophotometry and high performance liquid chromatography in pharmaceutical preparations.

Authors:  Fatma Ahmed Aly; Nahed El-Enany; Heba Elmansi; Amany Nabil
Journal:  Chem Cent J       Date:  2017-10-05       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.